For the quarter ended May 2025, Neogen (NEOG) reported revenue of $225.46 million, down 4.8% over the same period last year. EPS came in at $0.05, compared to $0.10 in the year-ago quarter.
The reported revenue represents a surprise of +1.9% over the Zacks Consensus Estimate of $221.26 million. With the consensus EPS estimate being $0.08, the EPS surprise was -37.5%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Food Safety: $161.83 million compared to the $155.05 million average estimate based on three analysts. The reported number represents a change of -3% year over year.
- Revenues- Animal Safety: $63.63 million versus the three-analyst average estimate of $66.2 million. The reported number represents a year-over-year change of -9%.
- Revenues- Food Safety- Natural Toxins & Allergens: $18.58 million versus the two-analyst average estimate of $18.35 million. The reported number represents a year-over-year change of -2.9%.
- Revenues- Animal Safety- Animal Care & Other: $7.7 million versus the two-analyst average estimate of $9.44 million. The reported number represents a year-over-year change of -21%.
- Revenues- Food Safety- Indicator Testing, Culture Media & Other: $83.21 million versus $81.37 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5.3% change.
- Revenues- Food Safety- Rodent Control, Insect Control & Disinfectants: $11.25 million compared to the $10.72 million average estimate based on two analysts. The reported number represents a change of +4.4% year over year.
- Revenues- Food Safety- Genomics Services: $6.33 million versus the two-analyst average estimate of $16.02 million. The reported number represents a year-over-year change of -0.3%.
- Revenues- Animal Safety- Life Sciences: $1.64 million compared to the $1.69 million average estimate based on two analysts. The reported number represents a change of -9.4% year over year.
- Revenues- Animal Safety- Veterinary Instruments & Disposables: $16.26 million versus the two-analyst average estimate of $16.64 million. The reported number represents a year-over-year change of -9.7%.
- Revenues- Animal Safety- Rodent Control, Insect Control & Disinfectants: $21.51 million versus $23 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -6.7% change.
- Revenues- Animal Safety- Genomics Services: $16.53 million versus the two-analyst average estimate of $6.01 million. The reported number represents a year-over-year change of -4.4%.
- Revenues- Food Safety- Bacterial & General Sanitation: $42.46 million versus $37.88 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -0.9% change.
View all Key Company Metrics for Neogen here>>>
Shares of Neogen have returned -4.9% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Neogen Corporation (NEOG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
